Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Precancerous Conditions 138 Lymphoma 35 Leukemia 34 Multiple Myeloma 33 Leukemia, Lymphocytic, Chronic, B-Cell 32 Neoplasms, Plasma Cell 31 Precursor Cell Lymphoblastic Leukemia-Lymphoma 29 Monoclonal Gammopathy of Undetermined Significance 29 Lymphoma, Non-Hodgkin 29 Lymphoma, Mantle-Cell 29 Lymphoma, Large-Cell, Immunoblastic 29 Lymphoma, Large B-Cell, Diffuse 29 Lymphoma, Follicular 29 Burkitt Lymphoma 28 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 27 Lymphoma, B-Cell, Marginal Zone 27 Hodgkin Disease 27 Myelodysplastic Syndromes 26 Immunoglobulin Light-chain Amyloidosis 26 Myeloproliferative Disorders 25 Lymphoma, T-Cell, Cutaneous 25 Immunoblastic Lymphadenopathy 25 Waldenstrom Macroglobulinemia 24 Lymphoma, Large-Cell, Anaplastic 24 Leukemia, Myeloid, Acute 24 Uterine Cervical Neoplasms 22 Primary Myelofibrosis 22 Leukemia, Large Granular Lymphocytic 22 Leukemia, Hairy Cell 22 Thrombocythemia, Essential 21

Interventions

Psychotherapy 1 Psilocybin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hospice × Other neoplasm × Clear all

NCT04950608 2026-02-17

PATH

Dana-Farber Cancer Institute

Phase 2 Completed

15 enrolled 26 charts

Hospice

Data powered by HemOnc (CC BY 4.0) Colophon ⚡